Content about Bloomberg

February 10, 2012

Bloomberg on Friday reported that Express Scripts intends to inform the Federal Trade Commission that the company has delivered all the data requested regarding its purchase of Medco Health Solutions on Friday, which will trigger a 30-day period for a decision from the FTC.

NEW YORK — Bloomberg on Friday reported that Express Scripts intends to inform the Federal Trade Commission that the company has delivered all the data requested regarding its purchase of Medco Health Solutions on Friday, which will trigger a 30-day period for a decision from the FTC.

Express Scripts declined to comment for the story, Bloomberg added.

December 20, 2011

Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

NEW YORK — Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

Type 1 diabetes is an autoimmune disorder in which the immune system attacks the pancreas's beta cells, but the drug, DiaPep277, stops that from happening, according to Bloomberg.

November 23, 2011

Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.

NEW YORK — Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.

November 16, 2011

When its blockbuster cholesterol drug Lipitor loses patent protection this month, Pfizer is hoping that pharmacy benefit managers will not dispense a generic version of the drug to its customers, according to published reports.

NEW YORK — When its blockbuster cholesterol drug Lipitor loses patent protection this month, Pfizer is hoping that pharmacy benefit managers will not dispense a generic version of the drug to its customers, according to published reports.

Pharmacy benefit managers Medco and Catalyst have agreed to block generic versions of Lipitor from reaching their customers until the end of May 2012, according to Bloomberg. Additionally, the company reportedly is in talks with Express Scripts to have the PBM also block generic versions from reaching customers as well.

October 31, 2011

New York City mayor Michael Bloomberg and health commissioner Thomas Farley received their seasonal flu vaccine on Saturday at a Duane Reade pharmacy in the Bronx, demonstrating the importance of taking steps to prevent the spread of the virus.

NEW YORK — New York City mayor Michael Bloomberg and health commissioner Thomas Farley received their seasonal flu vaccine on Saturday at a Duane Reade pharmacy in the Bronx, demonstrating the importance of taking steps to prevent the spread of the virus.

“Every year, New Yorkers lose their lives to the flu, and a flu shot is the single most important protection against getting sick and spreading the flu to others,” Bloomberg said. “I urge everyone to go to their doctor, local health clinic or pharmacy and get a flu shot as soon as they can.”

October 4, 2011

Mylan must pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.

NEW YORK — Mylan may have to pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.

Bloomberg reported that the Supreme Court rejected the drug maker's appeal of a 2005 jury verdict in a case that involved antitrust allegations regarding the drugs lorazepam and clorazepate.

September 29, 2011

The second season of "Extreme Couponing" debuted on TLC Wednesday evening, and with the new season came a renewed concern as to how extreme couponers will impact value promotions at retail.

SILVER SPRING, Md. — The second season of "Extreme Couponing" debuted on TLC Wednesday evening, and with the new season came a renewed concern as to how extreme couponers will impact value promotions at retail.

That may be one of the more significant concerns for retailers, according to a Bloomberg report published Wednesday — that promotions are attracting one-time buyers who cherry-pick their way through the weekly shopping trip in place of loyal consumers.

September 16, 2011

A report released Thursday by Bloomberg said that U.S. consumer confidence held last week at the second-lowest level of 2011 as the highest number of households in three years said it was a bad time to spend.

WASHINGTON — A report released Thursday by Bloomberg said that U.S. consumer confidence held last week at the second-lowest level of 2011 as the highest number of households in three years said it was a bad time to spend.

The Bloomberg Consumer Comfort Index was minus 49.3 in the period to Sept. 11, near the 2011 low of minus 49.4 reached in May. The buying climate gauge slumped to the lowest level since October 2008.

According to the report, the majority — 9-out-of-10 — of Americans polled had a negative view on the economy.

September 1, 2011

Pfizer and Dr. Reddy's have reached a settlement over the latter's efforts to launch a generic version of the world's top-selling drug, according to published reports.

NEW YORK — Pfizer and Dr. Reddy's have reached a settlement over the latter's efforts to launch a generic version of the world's top-selling drug, according to published reports.

August 31, 2011

The Mondays Campaigns — a nonprofit organization founded in 2005 in association with Columbia University's Mailman School of Public Health, Johns Hopkins' Bloomberg School of Public Health and Syracuse University's S.I. Newhouse School of Public Communications — is bringing its Healthy Monday initiative to Piggly Wiggly Carolina in September.

NEW YORK — The Mondays Campaigns — a nonprofit organization founded in 2005 in association with Columbia University's Mailman School of Public Health, Johns Hopkins'  Bloomberg School of Public Health and Syracuse University's S.I. Newhouse School of Public Communications — is bringing its Healthy Monday initiative to Piggly Wiggly Carolina in September.

August 30, 2011

Mylan will be banned temporarily from launching a generic drug for acne pending a federal court's decision whether or not to bar it, according to published reports.

NEW YORK — Mylan will be banned temporarily from launching a generic drug for acne pending a federal court's decision whether or not to bar it, according to published reports.

August 19, 2011

While Indian generic drug maker Ranbaxy Labs is expected by many to launch a generic version of a cholesterol drug made by Pfizer later this year, it may have to sell its rights to it if it can't win Food and Drug Administration approval in time, according to published reports.

NEW YORK — While Indian generic drug maker Ranbaxy Labs is expected by many to launch a generic version of a cholesterol drug made by Pfizer later this year, it may have to sell its rights to it if it can't win Food and Drug Administration approval in time, according to published reports.

Citing Credit Suisse analysts, Bloomberg reported that the FDA may delay approval of Ranbaxy's version of Lipitor (atorvastatin), which would prevent it from marketing the drug starting Nov. 30, as it has planned to do.

August 19, 2011

Generic drug maker Sandoz is suing Danish drug maker Novo Nordisk over a generic version of a drug used to treat diabetes, according to published reports.

NEW YORK — Generic drug maker Sandoz is suing Danish drug maker Novo Nordisk over a generic version of a drug used to treat diabetes, according to published reports.

Bloomberg reported that Sandoz, the generics arm of Swiss drug maker Novartis, was suing Novo Nordisk in a Detroit federal court, hoping the court would find that the Sandoz generic version of Novo Nordisk's Prandin (repaglinide) did not infringe on the latter company's patent covering the drug.

May 18, 2011

A newly launched prescription card offers discounts at more than 2,000 pharmacies in New York.

NEW YORK — A newly launched prescription card offers discounts at more than 2,000 pharmacies in New York.

May 17, 2011

A court in France has ordered generic drug maker Mylan to pay French drug maker Ipsen $24 million for allegedly misleading marketing of a drug, according to published reports.

PARIS — A court in France has ordered generic drug maker Mylan to pay French drug maker Ipsen $24 million for allegedly misleading marketing of a drug, according to published reports.

Bloomberg reported that Mylan had allegedly marketed the drug Vitalogink as a generic version of Ipsen’s Tanakan rather than as a “therapeutic equivalent.” Both drugs are derived from ginkgo biloba and are used to improve memory.

Mylan has said it will appeal the decision, Bloomberg reported.

May 9, 2011

New York City -- Massmart Holdings Ltd. promised to add jobs if Wal-Mart Stores is allowed to buy a controlling stake in the South African wholesaler, CEO Grant Pattison. His remarks were made on Monday at a tribunal in Pretoria, South Africa, that will determine whether Wal-Mart will be able to go through with the deal.

March 28, 2011

A report released Monday by the Commerce Department showed that consumer spending in the United States rose more than forecasted in February as incomes climbed.

WASHINGTON, D.C. — A report released Monday by the Commerce Department showed that consumer spending in the United States rose more than forecasted in February as incomes climbed.

Bloomberg News estimated spending would advance 0.5%.

Purchases increased 0.7% — the most since October 2010 — after advancing 0.3% the prior month. Incomes increased 0.3%, less than the 0.4% projected.

March 21, 2011

Generic drug maker Mylan is suing the Food and Drug Administration in an effort to prevent Gurgaon, India-based competitor Ranbaxy Labs from launching its generic version of Pfizer’s cholesterol medication Lipitor, according to published reports.

NEW YORK — Generic drug maker Mylan is suing the Food and Drug Administration in an effort to prevent Gurgaon, India-based competitor Ranbaxy Labs from launching its generic version of Pfizer’s cholesterol medication Lipitor, according to published reports.

March 17, 2011

Drug makers Gilead Sciences and Roche are suing Indian drug maker Natco Pharma concerning a generic version of an influenza treatment, according to published reports.

NEW YORK — Drug makers Gilead Sciences and Roche are suing Indian drug maker Natco Pharma concerning a generic version of an influenza treatment, according to published reports.

Bloomberg reported that Gilead and Roche were accusing Natco of patent infringement due to its efforts to gain approval from the Food and Drug Administration for a generic version of Tamiflu (oseltamivir phosphate). Natco became the first company to file for approval of a generic version in February.

January 21, 2011

It’s no coincidence that Publix and Wegmans are two companies that also routinely wind up at the top of customer service surveys — testimony that satisfied employees who enjoy their workplace generally add that special ingredient to customer service. Having a totally energized work force, and knowing what it takes to keep them that way, that's the "secret sauce" in retailing.

WHAT IT MEANS AND WHY ITS IMPORTANT — It’s no coincidence that Publix and Wegmans are two companies that also routinely wind up at the top of customer service surveys — testimony that satisfied employees who enjoy their workplace generally add that special ingredient to customer service. Having a totally energized work force, and knowing what it takes to keep them that way, that's the "secret sauce" in retailing.

December 21, 2010

A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

NEW YORK — A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

November 18, 2010

Johnson & Johnson and the U.S. government are suing two generic drug makers to stop...

NEW YORK — Johnson & Johnson and the U.S. government are suing two generic drug makers to stop them from launching a generic drug for HIV, according to published reports.

 

Bloomberg reported Thursday that Tibotec, a subsidiary of J&J, and the government were separately suing Mylan and Lupin over a generic version of the drug Prezista (darunavir ethanolate), alleging patent infringement.

 

 

October 24, 2010

Speculation has emerged that Eli Lilly may seek to acquire several other companies in light...

NEW YORK Speculation has emerged that Eli Lilly may seek to acquire several other companies in light of its difficulties winning approval for a long-acting diabetes treatment, according to published reports.

 

October 4, 2010

Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...

NEW YORK Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug made by Eisai, according to published reports.

Bloomberg reported Tuesday that the Indian drug maker had won 180 days’ exclusivity in which to market a generic version of Eisai’s Aricept (donepezil hydrochloride) tablets, pending final Food and Drug Administration approval, beating out Israel-based Teva Pharmaceutical Industries.

August 25, 2010

Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble,...

NEW YORK Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble, according to published reports.

Bloomberg reported Wednesday that Sanofi was unwilling to raise its offer of $70 per share for Genzyme, a Cambridge, Mass.-based company that has carved a niche for itself by manufacturing treatments for such rare genetic disorders as Fabry disease and Pompe disease but lately has been dogged by manufacturing problems.